Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Delayed Nasdaq Stockholm
Other stock markets
 10:04:06 2024-06-10 am EDT 		5-day change 1st Jan Change
6.137 SEK -2.66% Intraday chart for Clinical Laserthermia Systems AB -5.79% -77.76%
May. 31 Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue MT
May. 29 Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • One of the major weak points of the company is its financial situation.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CLINICAL LASERTHERMIA SYSTEMS AB Stock Clinical Laserthermia Systems AB
-77.76% 4.7M -
SISRAM MEDICAL LTD Stock Sisram Medical Ltd
-28.71% 225M -
LASEROPTEK CO., LTD. Stock Laseroptek Co., Ltd.
-32.85% 77.72M - -
MODULIGHT OYJ Stock Modulight Oyj
+13.29% 59.81M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. Ratings Clinical Laserthermia Systems AB